Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2011
07/14/2011US20110171667 Reaction medium for detecting and/or identifying bacteria of the legionella genus
07/14/2011US20110171666 Peptide-lipid constructs and their use in diagnostic and therapeutic applications
07/14/2011US20110171665 P-selectin associated with eosinophils as a marker for asthma and correlating with b-1 integrin activation
07/14/2011US20110171663 Microtrench and tumour proliferation assay
07/14/2011US20110171660 Use of ccr9, ccl25/teck, and integrin alpha4 in diagnosis and treatment of melanoma metastasis in the small intestine
07/14/2011US20110171659 Multipotent Adult Stem Cells, Sources Thereof, Methods of Obtaining and Maintaining Same, Methods of Differentiation Thereof, Methods of Use Thereof and Cells Derived Thereof
07/14/2011US20110171658 Method of quantifying polynucleotides using a stored calibration curve
07/14/2011US20110171657 Process for predicting the prognosis of squamous cell lung cancer
07/14/2011US20110171656 Method for normalizing the contents of biomolecules in a sample
07/14/2011US20110171655 Ph measurement for sequencing of dna
07/14/2011US20110171654 Allelic ladder loci
07/14/2011US20110171653 Method for detecting cryptosporidium
07/14/2011US20110171652 Cross primingamplification of target nucleic acids
07/14/2011US20110171651 Method for identifying a nucleic acid in a sample
07/14/2011US20110171650 Gene expression related to preeclampsia
07/14/2011US20110171649 Detection of nucleic acids by oligonucleotide probes cleaved in presence of endonuclease v
07/14/2011US20110171648 Method of detecting and quantifying hepatitis c virus
07/14/2011US20110171647 Method for quantifying or detecting dna
07/14/2011US20110171646 Microrna expression profile associated with pancreatic cancer
07/14/2011US20110171645 Methods of diagnosing acute cardiac allograft rejection
07/14/2011US20110171644 Multiplex capture of nucleic acids
07/14/2011US20110171643 Method, process, and kit for cancer diagnosis, prognosis, and aftercare
07/14/2011US20110171642 Analysing Methylation Specific PCR by Amplicon Melting
07/14/2011US20110171641 Gene Expression Markers of Recurrence Risk in Cancer Patients After Chemotherapy
07/14/2011US20110171640 Method for isolating cell free apoptotic or fetal nucleic acids
07/14/2011US20110171639 Polymer for detection of target substance, and method for detection of target substance
07/14/2011US20110171638 Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
07/14/2011US20110171637 Methods and nucleic acids for analyses of cellular proliferative disorders
07/14/2011US20110171636 Mono- and multi-element coded libs assays and methods
07/14/2011US20110171635 Nucleic acid enzyme biosensors for ions
07/14/2011US20110171634 Methods and devices for single-molecule whole genome analysis
07/14/2011US20110171633 Method to use gene expression to determine likelihood of clinical outcome of renal cancer
07/14/2011US20110171632 Loss of heterozygosity of the dna markers in the 12q22-23 region
07/14/2011US20110171631 Methods of diagnosing endometriosis
07/14/2011US20110171630 Methods and compositions for correlating genetic markers with cardiovascular disease
07/14/2011US20110171629 Nanostructured devices including analyte detectors, and related methods
07/14/2011US20110171628 Cervical screening algorithms
07/14/2011US20110171627 Zcytor19 heterodimeric cytokine receptor polynucleotides, polypeptides, antibodies and methods
07/14/2011US20110171323 Methods and kits to predict prognostic and therapeutic outcome in small cell lung cancer
07/14/2011US20110171316 Expression and assembly of human group c rotavirus-like particles and uses thereof
07/14/2011US20110171287 Use of Oligonucleotides with Modified Bases as Antiviral Agents
07/14/2011US20110171264 Protein Formulation
07/14/2011US20110171257 Herpes simplex virus amplicon vectors derived from primary isolates
07/14/2011US20110171253 Novel astrovirus
07/14/2011US20110171252 Streptococcus suis vaccines and diagnostic tests
07/14/2011US20110171249 Chimeric chikungunya virus and uses thereof
07/14/2011US20110171244 Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereof
07/14/2011US20110171238 Novel stra6 polypeptides
07/14/2011US20110171233 Antibodies Against Human Cytomegalovirus (HCMV)
07/14/2011US20110171232 Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth
07/14/2011US20110171230 Method of Identifying Agents that Promote Axonal Development
07/14/2011US20110171225 Novel Plasmodium Falciparum Gene Encoding Signal Peptide Peptidase and Method of Using Inhibitors Thereof for Inhibiting Malarial Infection
07/14/2011US20110171221 Compositions and methods for the treatment of a neoplasia
07/14/2011US20110171214 Efficient well being assessment and improved treatment protocol
07/14/2011US20110171205 Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor
07/14/2011US20110171203 Methods for treating neoplastic disease targeting o-linked n-acetylglucosamine modifications of cellular protein
07/14/2011US20110171200 Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound
07/14/2011US20110171197 Pon polypeptides, polynucleotides encoding same and compositions and methods utilizing same
07/14/2011US20110171196 Methods of treatment and uses for camkii and its interaction with hdacs and calpain
07/14/2011US20110171184 Method for Introducing a Pna Molecule Conjugated to a Positively Charged Peptide into the Cytosol and/or the Nucleus by Photochemical Internalisation (Pci)
07/14/2011US20110171183 Markers of Induced Pluripotent Stem Cells
07/14/2011US20110171176 Complement antagonists and uses thereof
07/14/2011US20110171173 Ifn-alpha/beta-independent mechanism of antiviral protection through a novel ligand-receptor pair: ifn- ligands engage a novel receptor ifn-rn (crf2-12) and il-10r2 (crf2-4) for signaling andinduction of biological activities
07/14/2011US20110171149 Skin Lightening Compositions
07/14/2011US20110171134 (6s)-5-methyltetrahydrofolic acid for therapy of tissue injury
07/14/2011US20110171132 Methods, Compounds, and Compositions for Treatment and Prophylaxis in the Respiratory Tract
07/14/2011US20110171130 A3 adenosine receptor antagonists and partial agonists
07/14/2011US20110171127 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
07/14/2011US20110170075 Device for chemical and biochemical reactions using photo-generated reagents
07/14/2011DE102009040716B4 Verwendung von CD154 zur Identifizierung und Abtrennung von nicht-regulatorischen T-Zellen aus einem Gemisch mit regulatorischen T-Zellen Use of CD154 for the identification and separation of non-regulatory T cells from a mixture with regulatory T cells
07/14/2011DE10052583B4 Verfahren zur Optimierung der molekularen Multiplex-Diagnostik von Microtissue Arrays mit Hilfe von Virtual Cell Nucleus Imageing Method for optimizing the multiplex molecular diagnosis of tissue micro arrays by means of Virtual Cell Nucleus Imageing
07/14/2011CA2787958A1 Methods for identifying drug resistant mycobacterium
07/14/2011CA2786644A1 Improved recovery of nucleic acids from magnetic glass particles
07/14/2011CA2786599A1 Fret-based method for the determination of protein phosphatase and kinase activity
07/14/2011CA2786545A1 Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof
07/14/2011CA2786473A1 Materials and methods for isothermal nucleic acid amplification
07/14/2011CA2784970A1 Novel pneumovirus compositions and methods for using the same
07/14/2011CA2784953A1 Humanized fc.gamma.r mice
07/14/2011CA2784429A1 Transgenic non-human animal and uses thereof
07/14/2011CA2784155A1 Mitf as a marker for predisposition to cancer
07/14/2011CA2784137A1 Assay for jc virus antibodies
07/14/2011CA2783858A1 Method to use gene expression to determine likelihood of clinical outcome of renal cancer
07/14/2011CA2783469A1 Analyte sensors comprising blended membrane compositions and methods for making and using them
07/13/2011EP2343766A1 Enzyme immobilization for use in biofuel cells and sensors
07/13/2011EP2343765A1 Bioanodes for use in biofuel cells
07/13/2011EP2343554A1 Biomarker for microdomain disorder
07/13/2011EP2343385A1 HPV detection and quantification by real-time multiplex amplification
07/13/2011EP2343384A2 Method for diagnosing non-small cell lung cancer
07/13/2011EP2343383A1 New detector probe acting by molecular recognition
07/13/2011EP2343382A1 Plasmonic force manipulation in nanostructures
07/13/2011EP2343381A1 Inspection method of airbone floating bacteria and its apparatus
07/13/2011EP2343374A1 Molecules of HDV nucleic acids, fragments and applications thereof
07/13/2011EP2343373A1 Polynucleotides and polypeptides involved in plant fiber development and methods of using same
07/13/2011EP2343372A1 Method for predicting pharmacological efficacy of anti-tnf antibody preparation on rheumatoid arthritis, and pharmacological efficacy prediction apparatus
07/13/2011EP2343367A1 Mutated Abl kinase domains
07/13/2011EP2343366A1 Mutated Abl kinase domains
07/13/2011EP2343365A1 Mutated Abl kinase domains
07/13/2011EP2343364A2 Tubulin regulatory elements for use in plants
07/13/2011EP2343361A1 Cell culture kit, screening method, and cell culture kit manufacturing method
07/13/2011EP2343315A2 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers